drugset / Trial / NCT00684476

Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings

NCT00684476 ↗

Phase 4 Completed 60 enrolled Meir Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Maintenance venom immunotherapy administered at 6-month intervals to bee-venom allergic patients failed to provide protection from systemic reactions after sting challenges. These patients should continue their immunotherapy at 1-3 month intervals.

Timeline

Start
2004-06
Primary completion
—
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject venom immunotherapy Unknown — —

Indications